We selected 96 previously identified GWAS/literature reported risk SNPs for cardio-metabolic traits (Kathiresan et al., 2008 (link); Kooner et al., 2011 (link); Willer et al., 2008 (link))(http://www.genome.gov/gwastudies) as described in detail in our ongoing unpublished work (Farook et al.) for this study. Genomic DNA was extracted from blood samples collected from the MA children who participated in the SAFARI study, using Qiagens’s QIAmp DNA 96 BLOOD KIT or QIAmp DNA BLOOD MINIKIT according to the manufacturer’s protocol. Genotyping of the 96 SNPs was done using the Illumina’s Goldengate Veracode Assay per the manufacturer’s protocol (Illumina, San Diego, CA; www.illumina.org).